# FDA Inspection 864614 - Boston Medical Center Corporation - February 03, 2014

Source: https://www.keypedia.com/records/fda_inspections/boston-medical-center-corporation/a08e6bb4-1388-49d2-8a6e-038b12cf4934
Source feed: FDA_Inspections

> FDA Inspection 864614 for Boston Medical Center Corporation on February 03, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 864614
- Company Name: Boston Medical Center Corporation
- Inspection Date: 2014-02-03
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1270738 - 2025-05-02](https://www.keypedia.com/records/fda_inspections/boston-medical-center-corporation/eacd3697-0bcd-46f0-8d8b-e9400efbaeeb)
- [FDA Inspection 1270738 - 2025-05-02](https://www.keypedia.com/records/fda_inspections/boston-medical-center-corporation/02e35a68-ac8c-479a-ae85-78d26691abe3)
- [FDA Inspection 1218229 - 2023-09-12](https://www.keypedia.com/records/fda_inspections/boston-medical-center-corporation/7934772d-2dac-4534-a116-47411800c3ed)
- [FDA Inspection 1091871 - 2019-05-16](https://www.keypedia.com/records/fda_inspections/boston-medical-center-corporation/5f7ea29c-b7e6-4a86-9358-cd0abaa5c7b3)
- [FDA Inspection 963517 - 2016-03-18](https://www.keypedia.com/records/fda_inspections/boston-medical-center-corporation/81980f7e-039f-430d-b073-5bfd2811ebc3)

Company: https://www.keypedia.com/companies/boston-medical-center-corporation/559902d3-29a6-4522-a2ac-28231bbc752f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d